ArticleThe international journal of cardiovascular imaging2026
The relationship between left atrioventricular coupling index and ischemic cerebrovascular events in patients with hypertrophic cardiomyopathy without atrial fibrillation.
Article in The international journal of cardiovascular imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Echocardiographic assessment of left atrioventricular coupling index: technical approaches and clinical implementation strategies.Frontiers in cardiovascular medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hypertrophic cardiomyopathy (HCM) can lead to various complications, such as arrhythmias, systemic thromboembolism, and heart failure. In addition to atrial fibrillation (AF), factors like an enlarged left atrial diameter, heart failure, and older age are associated with a higher risk of thromboembolic events in HCM patients. The left atrioventricular coupling index (LACI) is a new echocardiographic measure with promising potential to predict patient outcomes across different clinical scenarios. This study aimed to investigate the relationship between ischemic cerebrovascular events (CE) and the LACI in patients with HCM who do not have AF. This retrospective study examined 250 patients diagnosed with HCM, excluding those with AF. After applying exclusion criteria, 195 patients were included in the final analysis. Each participant underwent transthoracic echocardiography prior to the procedure, and LACIs were calculated for all patients. LACI was defined by the ratio of left atrial (LA) end-diastolic volume divided by left ventricular (LV) enddiastolic volume. Patients were monitored for 24 months to identify any occurrences of ischemic cerebrovascular events (CE). During a median follow-up of 24 months, the study’s primary outcome—ischemic CE + in HCM patients without AF—was significantly higher in those with higher LACI (%) (48 ± 12 vs. 66 ± 23, p = 0.042). Univariate logistic regression analysis revealed significant correlations between ischemic CE + in HCM patients without AF with smoking and LACI. Further analysis of these variables using the multivariate logistic regression analysis indicated that LACI (OR: 1.842, 95% CI: 1.332–2.548; p < 0.001) and smoking were independent predictors for the development of ischemic CE + in HCM patients without AF. In the ROC analysis, the LACI optimal cut-off value of > 0.61 (61%) predicted ischemic CE + in patients with HCM without AF, showing 62.5% sensitivity and 90.4% specificity. This study demonstrates the significance of LACI in predicting ischemic CE for patients with HCM without AF.
Indexed as
Identifiers
41549189What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.